X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-06-26 | QURE | Abi-Saab Walid | Chief Medical Officer | S - Sale | $4.36 | -1,447 | 115,253 | -1% | -$6,309 | ||||||
2024-06-17 | QURE | Caloz Pierre | COO | S - Sale | $4.81 | -2,936 | 115,707 | -2% | -$14,122 | ||||||
2024-06-17 | QURE | Klemt Christian | CFO | S - Sale | $4.80 | -1,611 | 164,837 | -1% | -$7,733 | ||||||
2024-06-13 | QURE | Post Leonard E | Dir | S - Sale | $5.14 | -2,222 | 15,999 | -12% | -$11,421 | ||||||
2024-06-13 | QURE | Potts Jeannette | GC | S - Sale | $4.98 | -4,781 | 91,819 | -5% | -$23,809 | ||||||
2024-06-13 | QURE | Springhorn Jeremy P. | Dir | S - Sale | $5.12 | -2,231 | 23,756 | -9% | -$11,423 | ||||||
2024-06-13 | QURE | Meek David D. | Dir | S - Sale | $5.12 | -2,229 | 20,252 | -10% | -$11,412 | ||||||
2024-06-13 | QURE | Balachandran Madhavan | Dir | S - Sale | $5.12 | -2,231 | 23,759 | -9% | -$11,423 | ||||||
2024-06-13 | QURE | Soteropoulos Paula | Dir | S - Sale | $5.14 | -2,220 | 20,203 | -10% | -$11,411 | ||||||
2024-06-13 | QURE | Gut Robert | Dir | S - Sale | $5.12 | -3,504 | 44,165 | -7% | -$17,940 | ||||||
2024-06-13 | QURE | Kaye Jack | Dir | S - Sale | $5.16 | -2,218 | 6,501 | -25% | -$11,445 | ||||||
2024-06-13 | QURE | Jacques Rachelle Suzanne | Dir | S - Sale | $5.14 | -2,221 | 14,408 | -13% | -$11,416 | ||||||
2024-02-26 | QURE | Caloz Pierre | COO | S - Sale | $6.47 | -9,455 | 85,643 | -10% | -$61,174 | ||||||
2024-02-26 | QURE | Klemt Christian | CFO | S - Sale | $6.38 | -15,906 | 116,948 | -12% | -$101,480 | ||||||
2024-02-26 | QURE | Kapusta Matthew C | CEO, MD | S - Sale | $6.35 | -27,904 | 440,839 | -6% | -$177,190 | ||||||
2023-09-18 | QURE | Dolmetsch Ricardo | Pres, R, D | S - Sale | $7.46 | -5,841 | 163,404 | -3% | -$43,574 | ||||||
2023-07-10 | QURE | Caloz Pierre | COO | S - Sale | $11.36 | -15,117 | 95,098 | -14% | -$171,729 | ||||||
| D | 2023-06-16 | QURE | Jacques Rachelle Suzanne | Dir | S - Sale+OE | $18.76 | -2,301 | 16,629 | -12% | -$43,167 | |||||
| D | 2023-06-16 | QURE | Soteropoulos Paula | Dir | S - Sale+OE | $18.99 | -2,275 | 22,423 | -9% | -$43,202 | |||||
| D | 2023-06-16 | QURE | Post Leonard E | Dir | S - Sale+OE | $18.83 | -2,291 | 18,221 | -11% | -$43,140 | |||||
| D | 2023-06-16 | QURE | Meek David D. | Dir | S - Sale+OE | $18.85 | -2,290 | 22,481 | -9% | -$43,167 | |||||
| D | 2023-06-16 | QURE | Kaye Jack | Dir | S - Sale+OE | $18.93 | -2,280 | 34,119 | -6% | -$43,160 | |||||
| D | 2023-06-16 | QURE | Gut Robert | Dir | S - Sale+OE | $18.88 | -3,228 | 47,669 | -6% | -$60,945 | |||||
| D | 2023-06-16 | QURE | Balachandran Madhavan | Dir | S - Sale+OE | $18.91 | -2,283 | 25,990 | -8% | -$43,172 | |||||
2023-06-16 | QURE | Caloz Pierre | COO | S - Sale | $18.80 | -2,920 | 110,215 | -3% | -$54,896 | ||||||
2023-06-16 | QURE | Klemt Christian | CFO | S - Sale | $18.94 | -1,587 | 132,854 | -1% | -$30,058 | ||||||
| D | 2023-06-16 | QURE | Springhorn Jeremy P. | Dir | S - Sale+OE | $18.88 | -2,286 | 25,987 | -8% | -$43,160 | |||||
2023-03-07 | QURE | Caloz Pierre | COO | S - Sale | $21.33 | -990 | 113,135 | -1% | -$21,117 | ||||||
2023-03-07 | QURE | Kuta Alexander Edward III | EVP, Operations | S - Sale | $21.36 | -585 | 90,381 | -1% | -$12,496 | ||||||
2023-03-07 | QURE | Klemt Christian | CFO | S - Sale | $21.36 | -986 | 134,441 | -1% | -$21,061 | ||||||
2023-03-07 | QURE | Dolmetsch Ricardo | Pres, R, D | S - Sale | $21.04 | -837 | 169,245 | 0% | -$17,610 | ||||||
2023-03-07 | QURE | Kapusta Matthew C | CEO, MD | S - Sale | $21.39 | -2,521 | 468,743 | -1% | -$53,924 | ||||||
2023-02-27 | QURE | Post Leonard E | Dir | S - Sale | $19.73 | -389 | 11,812 | -3% | -$7,675 | ||||||
| M | 2023-02-27 | QURE | Kuta Alexander Edward III | EVP, Operations | S - Sale | $20.18 | -6,726 | 90,966 | -7% | -$135,725 | |||||
2023-02-27 | QURE | Balachandran Madhavan | Dir | S - Sale | $19.99 | -384 | 19,573 | -2% | -$7,676 | ||||||
2023-02-27 | QURE | Soteropoulos Paula | Dir | S - Sale | $19.97 | -384 | 15,998 | -2% | -$7,668 | ||||||
2023-02-27 | QURE | Caloz Pierre | COO | S - Sale | $19.61 | -4,365 | 114,125 | -4% | -$85,608 | ||||||
| M | 2023-02-27 | QURE | Klemt Christian | CFO | S - Sale | $20.20 | -11,193 | 135,427 | -8% | -$226,075 | |||||
2023-02-27 | QURE | Dolmetsch Ricardo | Pres, R, D | S - Sale | $19.58 | -6,944 | 170,082 | -4% | -$135,964 | ||||||
| M | 2023-02-27 | QURE | Kapusta Matthew C | CEO, MD | S - Sale | $20.09 | -24,547 | 471,264 | -5% | -$493,252 | |||||
2023-02-27 | QURE | Springhorn Jeremy P. | Dir | S - Sale | $20.41 | -384 | 19,573 | -2% | -$7,837 | ||||||
2023-02-27 | QURE | Jacques Rachelle Suzanne | Dir | S - Sale | $20.02 | -384 | 10,230 | -4% | -$7,688 | ||||||
2023-02-27 | QURE | Kaye Jack | Dir | S - Sale | $19.99 | -384 | 27,699 | -1% | -$7,676 | ||||||
2023-02-27 | QURE | Meek David D. | Dir | S - Sale | $19.71 | -389 | 16,071 | -2% | -$7,667 | ||||||
| M | 2023-02-27 | QURE | Gut Robert | Dir | S - Sale | $20.79 | -1,968 | 42,197 | -4% | -$40,907 | |||||
| D | 2023-01-18 | QURE | Soteropoulos Paula | Dir | S - Sale+OE | $22.59 | -6,000 | 16,382 | -27% | -$135,540 | |||||
| DM | 2022-12-13 | QURE | Soteropoulos Paula | Dir | S - Sale+OE | $23.44 | -6,800 | 16,382 | -29% | -$159,384 | |||||
2022-12-09 | QURE | Dolmetsch Ricardo | Pres, R, D | S - Sale | $22.30 | -2,219 | 127,406 | -2% | -$49,484 | ||||||
2022-12-09 | QURE | Caloz Pierre | COO | S - Sale | $22.22 | -2,941 | 68,870 | -4% | -$65,349 | ||||||
2022-12-09 | QURE | Klemt Christian | CFO | S - Sale | $22.35 | -2,608 | 107,180 | -2% | -$58,289 | ||||||
2022-12-09 | QURE | Kuta Alexander Edward III | EVP, Operations | S - Sale | $22.34 | -2,338 | 95,652 | -2% | -$52,231 | ||||||
2022-12-09 | QURE | Kapusta Matthew C | CEO, MD | S - Sale | $22.44 | -6,648 | 368,481 | -2% | -$149,181 | ||||||
| D | 2022-11-29 | QURE | Soteropoulos Paula | Dir | S - Sale+OE | $25.38 | -6,200 | 16,382 | -27% | -$157,356 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |